• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number RRT07070070L
Device Problem Material Rupture (1546)
Patient Problem Hematoma (1884)
Event Date 03/01/2017
Event Type  Injury  
Manufacturer Narrative
The review of the manufacturing records verified that this lot met all pre-release specifications.(b)(4).Further investigation is being conducted and the information will be included in the final report.
 
Event Description
It was reported to gore that the patient was implanted with a gore-tex® stretch vascular graft in the femoral artery to perform a bypass procedure on (b)(6) 2017.On (b)(6) 2017, the patient presented with a hematoma on the implant side.Therefore the patient was converted to open surgery to cure the hematoma.It was reported to gore that when the hematoma was cured a rupture of the implanted gore-tex® stretch vascular graft was observed.It was stated that the graft rupture was visible next to the ringed section of the device.The anastomosis looked fine.The medical device was explanted.
 
Manufacturer Narrative
The device was returned to w.L.Gore & associates for investigation.Submitted in formalin were two gore-tex® vascular graft device fragments (vgf-1 & vgf-2) which had been transected prior to arrival at w.L.Gore and associates.Both fragments were light tan, largely devoid of tissue, had multiple areas of serration marks present on the abluminal surfaces, and the lumens were widely patent.Vgf-1 had no rings present and was cut in a beveled pattern and also longitudinally, consistent with site of anastomosis.Beveled and longitudinal cut edges were lined with holes and a full thickness tear was present.Multiple fragments of blue suture were present, looped through the material, along the beveled edge.Vgf-1 had also been transected at the opposite end with radial film disruption present; this pole appeared to align with vgf-2.Vgf-2 had been transected at both poles.One end had an area of irregular edge, consistent with the heel of the anastomosis, with multiple full thickness tears.Three rings remained intact and firmly adhered at the opposite end, eight removed ring sights were visible.Backlighting/ luminal lighting of the graft revealed no holes in the body of the graft or adjacent to the rings.Histopathological examination was not performed due to the paucity of adherent tissue.The device fragments were subjected to an enzymatic digestion process to remove biologic debris.Following digestion all fragments were examined for material disruptions with the aid of a stereomicroscope and scanning electron microscopy.Disruptions identified were not associated with handling or manufacturing process at w.L.Gore and associates.The disruptions are largely consistent with surgical procedures.Vgf-2 had multiple tears consistent with suture pull through due to tension on the graft; time point cannot be determined.There were no full thickness material disruptions adjacent to the ringed portion of graft suggestive of wall failure, nor was there evidence of graft rupture of the returned graft fragment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® STRETCH VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
barbara ulrich
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6420093
MDR Text Key70409698
Report Number2017233-2017-00135
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K933943
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 08/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/06/2021
Device Catalogue NumberRRT07070070L
Device Lot Number14733471
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2017
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/08/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-